Marissa F. Dockendorf

Statistics

Publications

Citations

1.1K

H-Index

Active since

2008

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Thomas Jefferson University

Celerion (United States)

Allergan (United States)

Marissa F. Dockendorf is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, clinical pharmacology, and pharmacokinetics.

ORCID

Publications per year

2008–2021

Publications

The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients

Matthew Kennedy, Andrew W. Stamford, Xia Chen et al. · Science Translational Medicine · 2016 · 417 citations

Life Sciences, Neuroscience, Pharmacology +17

Pharmacokinetics and Safety of Caspofungin in Older Infants and Toddlers

Michael Neely, Hasan S. Jafri, Nita L. Seibel et al. · Antimicrobial Agents and Chemotherapy · 2008 · 79 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

Safety, Tolerability and Pharmacokinetics of Doravirine, a Novel HIV Non-Nucleoside Reverse Transcriptase Inhibitor, after Single and Multiple doses in Healthy Subjects

Matt S. Anderson, Jocelyn Gilmartin, Caroline Cilissen et al. · Antiviral Therapy · 2014 · 78 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

An Integrated Strategy for Implementation of Dried Blood Spots in Clinical Development Programs

Prajakti A. Kothare, Kevin P. Bateman, Marissa F. Dockendorf et al. · The AAPS Journal · 2016 · 53 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

Facial and Vocal Markers of Schizophrenia Measured Using Remote Smartphone Assessments: Observational Study

Anzar Abbas, Bryan J. Hansen, Vidya Koesmahargyo et al. · JMIR Formative Research · 2021 · 51 citations · Full text

Social Sciences, Behavioral Sciences, Psychiatry +16

1–5 of 18